Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 31, Number 11—November 2025

Research

Monkeypox Virus Partial-Genome Amplicon Sequencing for Improvement of Genomic Surveillance during Mpox Outbreaks

Jiusheng Deng, Daisy McGrath, Kimberly Wilkins, Luis A. Haddock, Whitni Davidson, Demi B. Rabeneck, Joseph Madden, Vaughn Wicker, Adrienne Amuri-Aziza, Tony Wawina-Bokalanga, Placide Mbala-Kingebeni, Christina L. Hutson, Yu Li, and Crystal GiganteComments to Author 
Author affiliation: Chenega Enterprise Systems and Solutions, LLC, Chesapeake, Virginia, USA (J. Deng); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J. Deng, D. McGrath, K. Wilkins, L.A. Haddock, W. Davidson, D.B. Rabeneck, J. Madden, V. Wicker, C.L. Hutson, Y. Li, C. Gigante); University of Kinshasa, Kinshasa, Democratic Republic of the Congo (A. Amuri-Aziza, T. Wawina-Bokalanga, P. Mbala-Kingebeni)

Main Article

Table 3

Characteristics of formalin-fixed (nos. 41–45) or inconclusive (nos. 46–48) MPXV specimens from the United States and sequencing read depths over the 10-kb and 15-kb regions or the whole genome of MPXV for study of partial-genome amplicon sequencing for improvement of genomic surveillance during mpox outbreaks*

Specimen no. Source Year DNA concentration, ng/μL Ct 10-kb 15-kb Genome
41 Tissue 2022 39.4 17.1 576 347 9.6
42 Tissue 2022 6.3 17.1 981 1,065 0.1
43 Rectum 2023 56.4 17.4 794 977 17.9
44 Lung 2023 3.0 30.4 869 382 0.07
45 Tissue 2024 7.4 17.3 741 698 28.4
46 Swab 2024 0.0 37.1 69 1,391 NA
47 Swab 2024 0.0 37.3 15 691 NA
48 Swab 2024 0.0 37.2 359 1,092 NA
49 Swab 2024 0.0 38.4 25 155 NA

*Total DNA was extracted from formalin-fixed MPXV tissue specimens from different body sources of patients in the United States during 2022–2024 (nos. 41–45) or inconclusive specimens (nos. 46–49) with MPXV Ct >37. DNA concentrations (ng/µL), MPXV Ct values, and read depths over the 2 genomic regions (10-kb and 15-kb) derived from amplicon sequencing or over the whole genome (genome) of MPXV derived from metagenomic sequencing on DNA samples included. Whole-genome sequencing was not performed on 3 inconclusive specimens (nos. 46–48) or failed on specimen no.49; sequencing read depths over the whole genome of MPXV were not available. Ct, cycle threshold; MPXV, monkeypox virus; NA, not available.

Main Article

Page created: November 18, 2025
Page updated: December 10, 2025
Page reviewed: December 10, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external